Biomarkers for dementia in Latin American countries: Gaps and opportunities
Date
2022-01-15Author
Parra, Mario A.
Orellana, Paulina
León, Tomás
Cabello, Victoria
Henriquez, Fernando
Gómez, Rodrigo
Aválos, Constanza
Damian, Andrés
Slachevsky, Andrea
Ibañez, Agustín
Zetterberg, Henrik
Tijms, Betty M.
Yokoyama, Jennifer S.
Piña-Escudero, Stefanie D.
Cochran, J. Nicholas
Matallana, Diana L.
Acosta, Daisy
Allegri, Ricardo
Arias-Suárez, Bianca P.
Barra, Bernardo
Behrens, Maria Isabel
Brucki, Sonia M.
Busatto, Geraldo
Caramelli, Paulo
Castro-Suarez, Sheila
Contreras, Valeria
Custodio, Nilton
Dansilio, Sergio
Cruz-Puebla, Myriam de la
Cruz de Souza, Leonardo
Díaz, Monica M.
Duque, Lissette
Farías, Gonzalo A.
Ferreira, Sergio T.
Guimet, Nahuel Magrath
Kmaid, Ana
Lira, David
Lopera, Francisco
Mar Meza, Beatriz
Miotto, Eliane C.
Nitrini, Ricardo
Núñez, Alberto
O’Neill, Santiago
Ochoa, John
Pintado-Caipa, Maritza
França Resende, Elisa de Paula
Risacher, Shannon
Rojas, Luz Angela
Sabaj, Valentina
Schilling, Lucas
Sellek, Allis F.
Sosa, Ana
Takada, Leonel T.
Teixeira, Antonio L.
Unaucho-Pilalumbo, Martha
Duran-Aniotz, Claudia
Metadata
Show full item recordAbstract
Limited knowledge on dementia biomarkers in Latin American and Caribbean (LAC)
countries remains a serious barrier. Here, we reported a survey to explore the ongoing
work, needs, interests, potential barriers, and opportunities for future studies
related to biomarkers. The results show that neuroimaging is the most used biomarker
(73%), followed by genetic studies (40%), peripheral fluids biomarkers (31%), and cerebrospinal
fluid biomarkers (29%). Regarding barriers in LAC, lack of funding appears to
undermine the implementation of biomarkers in clinical or research settings, followed
by insufficient infrastructure and training. The survey revealed that despite the above
barriers, the region holds a great potential to advance dementia biomarkers research.
Considering the unique contributions that LAC could make to this growing field,
we highlight the urgent need to expand biomarker research. These insights allowed
us to propose an action plan that addresses the recommendations for a biomarker
framework recently proposed by regional experts
Collections
The following license files are associated with this item: